The Patent Finder

Aurobindo Pharma Ltd

10 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

0
Ending by 2030
Mar 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 2, 2027
    The maintenance fee for Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof (US 11,857,559) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 2 fees due Oct 28 to 30, 2027 · next Oct 28
  • 1 fee due Nov 7, 2027
    The maintenance fee for Naloxegol oxalate and solid dispersion thereof (US 11,974,996) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 11,096,945Pharmaceutical compositions of linagliptin and process for preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,632,043Premix formulation for parenteral use and packaging thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,836,693Process for the preparation of docosanol
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,974,996Naloxegol oxalate and solid dispersion thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,857,559Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,273,156Stable cariprazine formulations for oral use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,648,242Pharmaceutical Composition Comprising Pimavanserin, Process of Preparation and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 11,969,413Pharmaceutical compositions of deutetrabenazine and process for preparation thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,221,440Process for the preparation of trametinib acetic acid solvate
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,285,411Pharmaceutical composition comprising eluxadoline, process of preparation and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 10: 45 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 15 no status recorded

Showing 1 to 10 of 17, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/643,177Pharmaceutical Compositions of RimegepantApr 23, 2024Pending
18/204,237May 31, 2023No status recorded
18/105,795Extended Release Compositions of Pseudoephedrine or Its Pharmaceutically Acceptable Salt ThereofFeb 3, 2023Pending
17/875,117Jul 27, 2022No status recorded
16/870,840May 8, 2020No status recorded
16/982,548Mar 13, 2019No status recorded
16/955,566Dec 18, 2018No status recorded
16/767,102Nov 21, 2018No status recorded
16/646,081Sep 10, 2018No status recorded
16/311,584Jun 21, 2017No status recorded
10 of 17 applications shown.
Pro members see all 17 published applications.
Pro members: see all 17 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited